OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Orchestra BioMed Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$5.65+0.20 (+3.67%)

Close on Oct 19, 2026

Market cap: $360.54M
P/E (TTM): –
Dividend yield: –

Orchestra BioMed Holdings, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	33	2.64	2.76	3.53	–
Cost of Revenue	0.19	0.20	0.19	0.21	–
Gross Profit	33	2.43	2.57	3.32	–
Research & Development	58	43	34	22	–
Selling, General & Admin	27	24	20	14	–
General & Administrative	–	–	–	2.96	0.27
Advertising Expenses	–	–	–	–	0.12
Total Costs & Expenses	85	67	54	36	–
Operating Income	-52	-64	-52	-33	-0.39
Interest Expense	–	0.30	1.40	1.30	–
Interest & Investment Income	–	–	–	0.35	0.02
Other Non-Operating Income	–	-0.01	–	–	–
Asset Impairment Charges	0	0	0	–	–
Gain (Loss) on Investments	–	-0.07	-0.02	1.03	–
Income Tax Expense	0	–	–	–	–
Net Income incl. Noncontrolling Interests	-53	-61	-49	-34	-0.38
Net Income	-53	-61	-49	-34	-0.38
Net Income to Common	-53	-61	–	–	–
EPS (Basic)(per share)	-1.11	-1.66	-1.48	-2.24	-0.02
EPS (Diluted)(per share)	-1.11	-1.66	-1.48	-2.24	-0.02
Shares Outstanding (Basic, Weighted)(shares)	48	37	33	15	20
Shares Outstanding (Diluted, Weighted)(shares)	48	37	33	15	20
EBITDA	-51	-64	-51	-32	–
Net Interest Income	–	–	3.85	0.05	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 99.5%
Operating margin: -181.4%
Net margin: -184.6%
Return on equity, FY2025: –

Financial strength

Current ratio: 8.26
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 152.0%

Valuation

P/E ratio: –
Price to sales: 11.28
Price to book: –
Dividend yield: –